REBOA 使用后胎盘植入谱系疾病中的动脉血栓形成：病例系列。
Arterial thrombosis after REBOA use in placenta accreta spectrum: a case series.
机构信息
Fundación Valle del Lili, Abnormally Invasive Placenta Clinic, Cali, Colombia.
Universidad Icesi, Medicine Programe, Cali, Colombia.
出版信息
J Matern Fetal Neonatal Med. 2022 Nov;35(21):4031-4034. doi: 10.1080/14767058.2020.1846178. Epub 2020 Nov 18.
BACKGROUND
The use of resuscitative endovascular balloon of the aorta (REBOA) is a useful strategy for bleeding control in placenta accreta spectrum (PAS) management. The incidence of complications associated with this procedure is variable. We report three cases of arterial thrombosis associated with REBOA, and we also analyze the factors that facilitated its occurrence.
CASE REPORT
Three women with PAS, presented common femoral and external iliac arterial thrombosis after REBOA use. Among the contributing factors probably associated with thrombosis, we identified the absence of ultrasound guidance for vascular access and the not using of heparin during aortic occlusion.
CONCLUSIONS
REBOA use is not exempt from complications and must be performed by experienced groups applying strategies to reduce the risks of complications.
背景
使用主动脉腔内修复球囊（REBOA）是控制胎盘植入谱系（PAS）患者出血的一种有效策略。该操作相关并发症的发生率存在差异。我们报告了三例与 REBOA 相关的动脉血栓形成病例，并分析了导致其发生的因素。
病例报告
三例 PAS 患者在使用 REBOA 后出现股总动脉和髂外动脉血栓形成。可能与血栓形成相关的因素包括血管入路时未行超声引导，以及主动脉阻断时未使用肝素。
结论
REBOA 的使用并非没有并发症，必须由经验丰富的团队进行操作，并采取降低并发症风险的策略。
Zotero 插件